Conference call and webcast to be held at 4:30 p.m. ETNEW HAVEN, Conn., March 10, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics ...
Mendelian randomization revealed a potential protective role of IPF against large artery atherosclerosis stroke, but no significant links with other cardiovascular diseases. The study suggests ...
Trevi Therapeutics (TRVI) advances Haduvio for IPF cough/RCC; Phase 2 IPF data strong, but funding, safety & opioid-label ...
Hosted on MSN
6 tips for managing chronic fatigue with IPF
Chronic fatigue is a common symptom of idiopathic pulmonary fibrosis (IPF), and may affect as many as 95 percent of all individuals living with this condition.Fatigue can have a significant impact on ...
The Company will conduct two Phase 3 clinical trials of nalbuphine ER for the treatment of patients with IPF-related chronic coughFirst pivotal ...
IPF patients showed reduced anxiety and depression scores one month post-COVID-19 vaccination, indicating improved mental health. The study emphasized the heightened COVID-19 risk for IPF patients, ...
Idiopathic pulmonary fibrosis (IPF) is a serious lung condition involving scar tissue inside your lungs that makes it hard to breathe. It is a progressive condition, which means that it gets worse ...
PureTech Health (PRTC) announced results from ELEVATE IPF, a Phase 2b randomized, double-blind, active- and placebo-controlled, dose-ranging trial evaluating deupirfenidone at two dose levels three ...
Abbvie (ABBV) announced an update on their ongoing clinical study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results